Summary by Moomoo AI
Pioneer Pharmaceuticals Limited announced on 23 February 2024 that the company has adopted a comprehensive electronic publication of company communications, including directors' reports, financial reports and other documents, in accordance with Section 2.07 of the Securities Listing Rules of the Hong Kong Stock Exchange Limited. The arrangement, effective from 31 December 2023, aims to promote a paperless system. The Company informs non-registered shareholders that all future corporate communications will be made available via the company's website and the HKEXnews website and no longer print copies will be available. Non-registered shareholders are required to provide a valid email address to receive communications through the intermediary or consult the relevant website themselves. If a shareholder wishes to receive a printed newsletter, please complete the return form and contact the Hong Kong Register of Shares. THE COMPANY EMPHASIZES THAT IF THE COMMUNICATION IS NOT RECEIVED DUE TO THE PROVISION OF AN INCORRECT E-MAIL ADDRESS, THE COMPANY WILL BE CONSIDERED TO HAVE COMPLIED WITH THE LISTING RULES.